Cédric Bories

Title: Cédric Bories: Innovator in Azaindole Derivatives

Introduction

Cédric Bories is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of azaindole derivatives. With a total of 4 patents to his name, Bories is recognized for his innovative approaches to combating diseases such as cancer and immune system disorders.

Latest Patents

Bories' latest patents focus on azaindole derivatives as multi-kinase inhibitors. The first patent describes compounds of a specific formula and their pharmaceutically acceptable addition salts, solvates, enantiomers, and diastereoisomers. These compounds are designed to inhibit protein kinases that play a crucial role in various diseases, including cancers and immune system disorders. The second patent also centers on azaindole derivatives as inhibitors of protein kinases, emphasizing their potential therapeutic applications.

Career Highlights

Cédric Bories is currently associated with Oribase Pharma, where he continues to advance his research in the pharmaceutical field. His work is pivotal in the development of new treatments that target critical pathways in disease progression.

Collaborations

Bories collaborates with talented professionals in his field, including Gwénaël Cheve and Abdelaziz Yasri. These partnerships enhance the innovative capacity of his research and contribute to the success of their projects.

Conclusion

Cédric Bories stands out as a prominent inventor in the realm of medicinal chemistry, particularly through his work on azaindole derivatives. His contributions are vital in the ongoing fight against serious health conditions, showcasing the importance of innovation in the pharmaceutical industry.